Mometason Pannonpharma (Mometasone Furoate)

Mometasone furoate, the active ingredient in Mometason, is a glucocorticoid presented as a nasal spray for intranasal use. It reduces inflammation in the nasal passages and is indicated for allergic rhinitis, seasonal allergic rhinitis and nasal polyps in both adults and children.

GNH USA supplies Mometason as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, with distribution across EU and other regulated markets, ensuring quality and regulatory compliance.

Mometason (mometasone furoate) is a nasal corticosteroid that acts on inflammatory pathways of the nasal mucosa. - Allergic rhinitis: relieves nasal congestion, itching, sneezing and rhinorrhea. - Seasonal allergic rhinitis: controls symptoms triggered by pollen or seasonal allergens. - Nasal polyps: reduces polyp size and improves nasal airflow.

Mometason may cause local and systemic adverse reactions, most of which are mild and reversible.

Common Side Effects: - Nasal irritation or burning: mild discomfort in the nostrils. - Headache: occasional mild headache. - Epistaxis: nosebleeds. - Unpleasant taste: bitter taste after use.

Serious or Rare Side Effects: - Nasal septal perforation: rare tissue damage. - Vision changes: blurred vision or cataract formation. - Adrenal suppression: systemic glucocorticoid effect with prolonged use. - Severe allergic reaction: anaphylaxis, hives, swelling. - Increased intra‑ocular pressure: risk of glaucoma.

Before using Mometason, consider the following precautions. - Pregnancy: safety not established; use only if benefit outweighs risk. - Pediatric use: safety profile established for children aged 2 years and older. - Systemic corticosteroid use: avoid concurrent high‑dose systemic steroids. - Infection: monitor for fungal or bacterial sinus infections. - Surgery: discontinue before nasal or sinus surgery as advised by the surgeon. - Store at ambient temperature below 25°C: keep in original container, protect from moisture and direct sunlight.

Mometason can interact with other medicines; review the following.

Major Interactions (Avoid): - Systemic corticosteroids: additive systemic glucocorticoid effects. - Strong CYP3A4 inhibitors (e.g., ketoconazole, itraconazole): may increase local exposure. - Antifungal azoles: similar risk of increased exposure.

Moderate Interactions (Monitor Closely): - Nasal decongestants: may increase local irritation. - Antihistamines: generally safe but monitor symptom control. - Live vaccines: effectiveness may be reduced; consider timing of vaccination.